Clinical Trials Directory

Trials / Completed

CompletedNCT04526054

Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients

Longitudinal and Comparative Study of Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients. This study aimed to detect these disturbances among positive COVID-19 patients (symptom not initially highlighted by the patient and not sought by caregivers) in order to allow early management of olfactory and gustatory dysfunction.

Detailed description

Several medical teams have recently shown that disturbances of smell and taste are common and can be a precursor and even an isolated sign of COVID-19 involvement. Preliminary results suggest the presence of clinical MRI abnormalities, particularly in the olfactory bulbs in anosmic patients with COVID-19. Anosmia and taste disturbance are early warning signs that could be important in improving the detection and diagnosis of COVID-19, and also in monitoring disease. In addition, disturbances in smell and taste could be an aid in establishing the prognosis of the clinical course of the viral disease. The question of olfactory recovery is also fundamental. To date, we do not know the possibilities of recovery from COVID-19 post viral anosmia. ENT exams, olfactometry and MRI are proposed to study these phenomena.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTENT examENT examination of the nasal cavity: nasofibroscopy and anterior rhinoscopy.
DIAGNOSTIC_TESTOlfactometryOlfactometry test using odorous pens (Sniffin's stick test).
DIAGNOSTIC_TESTBrain MRIBrain MRI focused on the olfactory bulbs (3 teslas).

Timeline

Start date
2020-09-03
Primary completion
2021-09-03
Completion
2021-09-03
First posted
2020-08-25
Last updated
2022-08-03

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04526054. Inclusion in this directory is not an endorsement.